The orthobiologics market research report has been added to Technavio’s catalog. The market is anticipated to…
Blog
iMagnum Healthcare expands itself into a Technology and Services provider in Revenue Cycle Management Industry
iMagnum Healthcare, a technology agnostic revenue cycle management services provider, today announced its transformationas a Technology…
Athletico Physical Therapy Clinician Care Recognized as ‘Exceptional’ by Centers for Medicare and Medicaid Service
Athletico Physical Therapy, a leader in physical and occupational therapy, voluntarily participated in CMS’s 2020 Quality Payment…
Applied Food Diagnostics Unveils Cannabis Pathogen Screen Test for Shiga-toxin Producing E. coli, Salmonella and Aspergillus
Applied Food Diagnostics, Inc., a food science solutions company, is pleased to announce the Cannabis Pathogen…
Simplex Health Launches FITNatal
Simplex Health, the leading provider of evidence-based medical nutrition therapies is thrilled to announce the launch…
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model…
Announcing Awards Of Community Heart & Soul® Seed Grants
Community Heart & Soul is pleased to award its first three $10,000 Seed Grants to Akron and Westfield, Iowa; Cambridge, Illinois; and Winchendon,…
Nektar Therapeutics Reports Second Quarter 2021 Financial Results
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2021. Cash and investments…
Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),…
Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer…